NIH-funded research R01 grant

Finding new ways to protect against artery disease

Official title: Identifying novel atheroprotective mechanisms

Funded at Clemson University · NIH-10942481 · Data updated 2026-11-12

This study is looking at how certain proteins in your blood vessel cells can help get rid of cholesterol from your arteries, which might help prevent heart disease, and it aims to find new ways to treat this condition that affects many people.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionClemson University
NIH-funded
Lab location1 site (Clemson, United States)
Project startSeptember 29, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$381,250
NIH project number1R01HL175166-01
Project IDNIH-10942481 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for atherosclerosis or those already diagnosed with the condition.

Less likely to help

Patients with conditions unrelated to cholesterol accumulation or atherosclerosis may not benefit from this research.

What this research studies

This research investigates how certain proteins in vascular smooth muscle cells can help remove cholesterol from arteries, potentially preventing atherosclerosis, which is a major cause of heart attacks and strokes. The study focuses on two specific transport proteins, ABCA1 and ABCG1, to understand their roles in cholesterol removal and whether increasing their expression can protect against artery disease. By examining how these proteins interact with cholesterol, the research aims to identify new therapeutic strategies for treating atherosclerosis. Patients may benefit from insights that could lead to more effective treatments for heart disease.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly reduce the risk of heart attacks and strokes for patients with atherosclerosis.

How similar studies have gone: Previous research has shown promise in targeting cholesterol transport mechanisms, suggesting that this approach could lead to meaningful advancements in atherosclerosis treatment.

Where this research is happening

  • Clemson University
    Clemson, United States
    Active

Researchers

  • Principal investigator: Stamatikos, Alexis — Clemson University
  • Study coordinator: Stamatikos, Alexis

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.